By adding a novel germline large deletion to the repertoire of germline CDKN2A mutations, our data contribute to an enlargement of the spectrum of mutations identified in melanoma-prone families and improve the estimate of the prevalence of this type of lesion, as the work was performed on the largest family dataset to date. This evidence concerns the gene CDKN2A and melanoma.